Back to today’s briefing

Story perspectives

Amneal Recalls Contaminated Ropivacaine; Q’Apel Halts Device

4/19/2025

30 6

Summary

Story summary

Amneal Pharmaceuticals is urgently recalling two lots of Ropivacaine Hydrochloride Injection over fears of harmful polypropylene fiber contamination, which could lead to serious inflammation and organ damage. In a related move, Q’Apel Medical is halting its 072 Aspiration System following FDA warnings about its design. Both companies are actively reaching out to customers for product returns.

1 of 1

Story summary

Amneal Pharmaceuticals is urgently recalling two lots of Ropivacaine Hydrochloride Injection over fears of harmful polypropylene fiber contamination, which could lead to serious inflammation and organ damage. In a related move, Q’Apel Medical is halting its 072 Aspiration System following FDA warnings about its design. Both companies are actively reaching out to customers for product returns.